Doxorubicin hydrochloride CAS: 25316-40-9

CAS NO: 25316-40-9
Doxorubicin hydrochloride
Chemical Name: Doxorubicin hydrochloride
Molecular Formula: C27H30ClNO11
Formula Weight: 579.98
CAS No.: 25316-40-9
Description Review
Description

Doxorubicin hydrochloride is an antineoplastic agent, meaning it is used to treat cancer. It belongs to a class of drugs known as anthracyclines and works by interfering with the DNA of cancer cells, preventing them from dividing and growing. Doxorubicin hydrochloride is commonly used to treat breast cancer, lymphoma, leukemia, and other types of cancer.

Chemical Name:

(8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride

Molecular Formula:

C27H30ClNO11

Formula Weight:

579.98 g/mol

CAS No:

25316-40-9

Top Ten Keywords from Google and Synonyms:

  1. Doxorubicin hydrochloride side effects
  2. Doxorubicin hydrochloride mechanism of action
  3. Doxorubicin hydrochloride dosage
  4. Doxorubicin hydrochloride administration
  5. Doxorubicin hydrochloride in breast cancer
  6. Doxorubicin hydrochloride for lymphoma
  7. Doxorubicin hydrochloride chemotherapy
  8. Doxorubicin hydrochloride cardiac toxicity
  9. Doxorubicin hydrochloride trade name
  10. Adriamycin

Synonyms:

  • Hydroxydaunorubicin hydrochloride
  • Rubex
  • Doxil
  • Caelyx
  • Myocet

Health Benefits of Doxorubicin Hydrochloride:

Doxorubicin hydrochloride is primarily used to treat cancer, particularly breast cancer, lymphoma, and leukemia. It works by interfering with the DNA of cancer cells, preventing them from dividing and growing. This can help to slow or stop the progression of cancer in affected individuals.

Potential Effects of Doxorubicin Hydrochloride:

  • May slow or stop the growth of cancer cells
  • May prevent the spread of cancer to other parts of the body
  • May improve symptoms associated with cancer, such as pain or fatigue

Product Mechanism:

Doxorubicin hydrochloride works by intercalating into DNA strands, which prevents the strands from separating during replication. This ultimately leads to cell death and prevents the growth and spread of cancer cells.

Safety:

Doxorubicin hydrochloride can cause serious side effects, including bone marrow suppression, gastrointestinal toxicity, and cardiac toxicity. It may also increase the risk of developing a secondary cancer, such as leukemia. Due to its potential for serious side effects, doxorubicin hydrochloride should only be administered under the supervision of a healthcare provider who has experience with this medication.

Side Effects:

Common side effects of doxorubicin hydrochloride include nausea, vomiting, hair loss, fatigue, and mouth sores. More serious side effects can occur, including bone marrow suppression, gastrointestinal toxicity, and cardiac toxicity. Patients receiving doxorubicin hydrochloride should undergo regular monitoring for these potential side effects.

Dosing Information:

The dosing of doxorubicin hydrochloride varies depending on the specific type of cancer being treated and other factors, such as the patient's age and overall health. It is typically administered via intravenous infusion and should only be given by a trained healthcare professional.

Conclusion:

Doxorubicin hydrochloride is an important medication used in the treatment of various types of cancer. While it has the potential to slow or stop the growth of cancer cells, it can also cause serious side effects, including bone marrow suppression, gastrointestinal toxicity, and cardiac toxicity. Patients receiving doxorubicin hydrochloride should be closely monitored for these potential side effects and receive regular check-ups from their healthcare provider. If you have questions or concerns about doxorubicin hydrochloride, speak with your healthcare provider to learn more about this medication and whether it is right for you

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code
Message Us